By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Response Biomedical today reported that its first-quarter 2010 revenues fell 43 percent and its net loss jumped 54 percent from the first quarter of 2009.

The Vancouver, BC-based molecular diagnostics firm brought in total revenues of C$1.5 million (US$1.5 million) for the three months ended March 31, compared to C$2.7 million for the first quarter of 2009. Its clinical product sales were down around 29 percent at C$1.2 million from C$1.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.